Jaguar Animal Health Inc (NASDAQ:JAGX) And Napo Releases Commercial Updates


Jaguar Animal Health Inc (NASDAQ:JAGX) an animal health firm focused on advancing and commercializing premium gastrointestinal products for production and companion animals, high value horses and foals, and Napo Pharmaceuticals, Inc. a human health firm advancing and commercializing innovative gastrointestinal prescription products from crops utilized plants used in rainforest areas, released several commercial updates.

The details

Jaguar is introducing a national TV advertising campaign for Neonorm™ Foal as well as a radio campaign in major dairy markets for Neonorm™ Calf. The two products are company’s lead non-prescription offerings. Neonorm™ Foal is a clinically-assessed, non-drug product working as an anti-diarrheal in neonatal horses.

As it is known, Diarrhea comes in the list of the most common clinical ailments in foals, particularly within the first month of life. The devastating impact of dehydration that often arise from secretory diarrhea in foals can grow quickly, precipitate grave health effects and result in death.

Neonorm™ Calf has been designed and clinically tested to assist proactively hold fluid in dairy calves and decrease the severity of diarrhea, helping calves in avoiding debilitating, serious levels of dehydration linked with scours.

Jaguar’s Neonorm™ Foal television campaign will comprise a 30-second commercial and it will be showcased during prime time hours in evening on RFD-TV. At the same time, Neonorm™ Calf radio campaign will comprise of a 30-second spot broadcasting this month in early hours on “DairyLine”, a program that has strong coverage in all dairy producing areas in the United States.

The radio and TV ads showcase two new contact channels intended to assist support sales and establish the Neonorm brand. In support of sales plans, Jaguar recently developed an e-commerce segment on its corporate website that enables end-user consumers to buy Neonorm™ Foal and Neonorm™ Calf directly from company, and introduced a content-filled blog.

Moreover, the firm has been targeting bovine veterinarians, equine veterinarians, dairy farmers, and the breeders, trainers and owners of horses, via social networking sites during Q1 2017.

This report is for information purposes only, and is neither a solicitation or recommendation to buy nor an offer to sell securities. Financials Trend is not-a-registered-investment-advisor. Financials Trend is not a broker-dealer. Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. Financials Trend accepts no liability for any losses arising from an investor's reliance on the use of this material. Financials Trend sometimes gets compensated up to one hundred and fifty thousand dollars per month for featuring particular stocks. See site disclaimer for complete compensation. Financials Trend and its affiliates or officers currently hold no shares of these stocks. Financials Trend and its affiliates or officers will purchase and sell shares of common stock of these stocks, in the open market at any time without notice. Financials Trend will not update its purchases and sales of these stocks in any future postings on Financials Trend's websites. Certain information included herein is forward-looking within the context of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. The words "may", "would," "will," "expect," "estimate," "anticipate," "believe," "intend," " project," and similar expressions and variations thereof are intended to identify for ward-looking statements. Such forward- looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. *Financials Trend does not set price targets on securities. Never invest into a stock discussed on this web site or in this email alert unless you can afford to lose your entire investment.